25 July 2017
25 July 2017
UK Olympic sprinter James Ellington has joined forces with the UK´s Invibio Biomaterial Solutions and CarboFix Orthopedics in his quest to return to athletics competition after a devastating motorcycle accident earlier this year.
CarboFix and Invibio develop innovative biomaterials and devices that have the potential to change the treatment of trauma fractures.
The life-changing experience of a severe head-on collision of his motorbike with a car hasn’t stopped James Ellington from fighting for his goals, despite having his legs and pelvis completely smashed.
“In extreme situations, it’s important not to lose faith and to consider all (therapeutic) options available,” explains Ellington. “I had a severe tibia fracture, and was offered two choices to fix it: a traditional titanium nail or a CarboFix nail using a relatively new, but promising carbon fibre composite technology. For me, it’s all about giving myself the best chance of achieving my goal and returning to competitive athletics. I chose the CarboFix nail because it’s lighter weight and for its faster healing potential.”
“The rod is made from a new composite polymer," he explains. "It’s strong, in a way that’s similar to metal implants, but not as stiff, which means it has the capability to stress the bone more and provide some micro-motion, so it works more like natural bone. The idea is that this will help support a quicker recovery – which is what convinced me this was the right path for me.”
The sprinter considers himself lucky: because he survived, is not paralysed, is walking again and is so far on a good recovery path that may also include running in the future.
With trauma implants made from Invibio’s PEEK-OPTIMA Ultra-Reinforced, a composite polymer, CarboFix Orthopedics is hoping to support Ellington and other patients in a similar position.
“The aim itself to get back on track is fantastic, whether that’s the athletic track or returning to other individual recovery goals," says Ron Szekely, the company's Vice President of Sales and Marketing. "This can be an important driver for rehabilitation. In addition to dedication and enthusiasm, patients need to have access to innovative medical devices that can support this. At CarboFix we believe in the potential of changing trauma treatment to improve the quality of life for many patients.”
"James Ellington´s passion for progress is the common denominator and connecting link between himself and Invibio,” explains Medical Business Unit Director, John Devine of Invibio Biomaterial Solutions. “Metals have been used to treat trauma fractures for decades, but patient demands for a quicker recovery with fewer device breakages coupled with the global increase in patient risk factors such as obesity and diabetes mean we need to be open to progress. That includes being open to the possibility that new innovative carbon fibre reinforced devices made from less stiff materials could really change how successful surgery and patient recovery is. The medical (device) industry itself very often and for good reasons, has to make small albeit important steps, to overcome challenges and achieve substantial progress towards the ultimate objective of improving patient outcomes and quality of life. James knows exactly how that feels and his positive attitude and firm belief in capabilities and future performance is another point we have in common.”
Cobra International will showcase a range of composite products at CAMX 2018, including carbon fibre components for the automotive, transportation, marine, water sports and luxury sectors.
Cobra International is celebrating its 40th year and has commissioned a book that will look at 40 key projects and 40 key people that were integral to the company’s growth. ‘Klaus Simmer and The King Cobra: A breakthrough in surfboard design and production technology’ is an extract article from this book and a breakthrough composites product for Cobra, establishing its presence as a manufacturer of high performance windsurf boards and creating global visibility for the Cobra brand.